Complications Associated with Parenteral Nutrition in the Neonate

Clinics in Perinatology

Volumn 41, Issue 2, 2014, Pages 331-345

  Calkins, Kara L ^a   Venick, Robert S ^a   Devaskar, Sherin U ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Infections; Lipids; Neonates; Parenteral nutrition; Parenteral nutrition associated liver disease

Indexed keywords

AMINO ACID; ANTIOXIDANT; FISH OIL; LIPID EMULSION; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHYTOSTEROL;

AMINO ACID RELATED COMPLICATION; CATHETER INFECTION; CHILD GROWTH; COMPLICATION; DEVELOPMENTAL DISORDER; DISEASE COURSE; DRUG DOSE REDUCTION; ESSENTIAL FATTY ACID DEFICIENCY; FOOD COMPOSITION; GLUCOSE INTOLERANCE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INFLAMMATION; INTRAVENOUS FEEDING; LIPID COMPOSITION; LIVER DISEASE; MEDICAL RESEARCH; METABOLIC DISORDER; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NUTRITIONAL INTOLERANCE; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; LIVER DISEASES; PREMATURITY;

HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LIVER DISEASES; PARENTERAL NUTRITION;

EID: 84901457322     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2014.02.006     Document Type: Review

References (77)

1. Christensen R.D., Henry E., Wiedmeier S.E., et al. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol 2007, 27(5):284-290.
2. Squires R.H., Duggan C., Teitelbaum D.H., et al. Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium. J Pediatr 2012, 161(4):723-728.
3. Arnold M. Is the incidence of gastroschisis rising in South Africa in accordance with international trends? A retrospective analysis at Pretoria Academic and Kalafong Hospitals, 1981-2001. S Afr J Surg 2004, 42(3):86-88.
4. Poindexter B.B., Langer J.C., Dusick A.M., et al. Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcome. J Pediatr 2006, 148(3):300-305.
5. Sekabira J., Hadley G.P. Gastroschisis: a third world perspective. Pediatr Surg Int 2009, 25(4):327-329.
6. Stephens B.E., Walden R.V., Gargus R.A., et al. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics 2009, 123(5):1337-1343.
7. Bradnock T.J., Marven S., Owen A., et al. Gastroschisis: one year outcomes from national cohort study. BMJ 2011, 343:d6749.
8. Mills J.A., Lin Y., Macnab Y.C., et al. Perinatal predictors of outcome in gastroschisis. J Perinatol 2010, 30(12):809-813.
9. Nandivada P., Carlson S.J., Cowan E., et al. Role of parenteral lipid emulsions in the preterm infant. Early Hum Dev 2013, 89(Suppl 2):S45-S49.
10. Le H.D., Meisel J.A., de Meijer V.E., et al. The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2009, 81(2-3):165.
11. Robinson D.T., Carlson S.E., Murthy K., et al. Docosahexaenoic and arachidonic acid levels in extremely low birth weight infants with prolonged exposure to intravenous lipids. J Pediatr 2013, 162(1):56-61.
12. Boden G. Effects of free fatty acids on gluconeogenesis and glycogenolysis. Life Sci 2003, 72(9):977-988.
13. Hey E. Hyperglycaemia and the very preterm baby. Semin Fetal Neonatal Med 2005, 10(4):377-387.
14. Beardsall K., Vanhaesebrouck S., Ogilvy-Stuart A.L., et al. Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study. J Pediatr 2010, 157(5):715-719.e1-3.
15. Hays S.P., Smith E.O., Sunehag A.L. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006, 118(5):1811-1818.
16. Cober M.P., Killu G., Brattain A., et al. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr 2012, 160(3):421-427.
17. Venick R.S., Calkins K. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease. Curr Opin Organ Transplant 2011, 16(3):306-311.
18. Simmer K., Rao S.C. Early introduction of lipids to parenterally-fed preterm infants. Cochrane Database Syst Rev 2005, (2). CD005256.
19. Vlaardingerbroek H., Veldhorst M.A., Spronk S., et al. Parenteral lipid administration to very-low-birth-weight infants-early introduction of lipids and use of new lipid emulsions: a systematic review and meta-analysis. Am J Clin Nutr 2012, 96(2):255-268.
20. Vlaardingerbroek H., Vermeulen M.J., Rook D., et al. Safety and efficacy of early parenteral lipid and high-dose amino acid administration to very low birth weight infants. J Pediatr 2013, 163(3):638-644.e1-5.
21. Beardsall K., Vanhaesebrouck S., Ogilvy-Stuart A.L., et al. Early insulin therapy in very-low-birth-weight infants. N Engl J Med 2008, 359(18):1873-1884.
22. Chacko S.K., Ordonez J., Sauer P.J., et al. Gluconeogenesis is not regulated by either glucose or insulin in extremely low birth weight infants receiving total parenteral nutrition. J Pediatr 2011, 158(6):891-896.
23. Mahaveer A., Grime C., Morgan C. Increasing early protein intake is associated with a reduction in insulin-treated hyperglycemia in very preterm infants. Nutr Clin Pract 2012, 27(3):399-405.
24. Thureen P.J., Melara D., Fennessey P.V., et al. Effect of low versus high intravenous amino acid intake on very low birth weight infants in the early neonatal period. Pediatr Res 2003, 53(1):24-32.
25. Blanco C.L., Falck A., Green B.K., et al. Metabolic responses to early and high protein supplementation in a randomized trial evaluating the prevention of hyperkalemia in extremely low birth weight infants. J Pediatr 2008, 153(4):535-540.
26. Dinerstein A., Nieto R.M., Solana C.L., et al. Early and aggressive nutritional strategy (parenteral and enteral) decreases postnatal growth failure in very low birth weight infants. J Perinatol 2006, 26:436-442.
27. Hay W.W., Thureen P.J. Early postnatal administration of intravenous amino acids to preterm, extremely low birth weight infants. J Pediatr 2006, 148(3):291-294.
28. Blanco C.L., Gong A.K., Green B.K., et al. Early changes in plasma amino acid concentrations during aggressive nutritional therapy in extremely low birth weight infants. J Pediatr 2011, 158(4):543-548.e1.
29. Blanco C.L., Gong A.K., Schoolfield J., et al. Impact of early and high amino acid supplementation on ELBW infants at 2 years. J Pediatr Gastroenterol Nutr 2012, 54(5):601-607.
30. Gravari E., Radmacher P.G., Adamkin D.H., et al. Amino acid profiles and serial blood urea nitrogen levels in infants less than 1250 g receiving early parenteral nutrition. J Neonatal Perinatal Med 2012, 5(2):149-153.
31. Poindexter B.B., Ehrenkranz R.A., Stoll B.J., et al. Effect of parenteral glutamine supplementation on plasma amino acid concentrations in extremely low-birth-weight infants. Am J Clin Nutr 2003, 77(3):737-743.
32. Denne S.C., Poindexter B.B. Evidence supporting early nutritional support with parenteral amino acid infusion. Semin Perinatol 2007, 31(2):56-60.
33. Dusick A.M., Poindexter B.B., Ehrenkranz R.A., et al. Growth failure in the preterm infant: can we catch up?. Semin Perinatol 2003, 27(4):302-310.
34. Cole C.R., Hansen N.I., Higgins R.D., et al. Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months. Pediatrics 2008, 122(3):e573-e582.
35. Willis T.C., Carter B.A., Rogers S.P., et al. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 2010, 34(1):32-37.
36. Fitzgibbons S.C., Jones B.A., Hull M.A., et al. Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. J Pediatr Surg 2010, 45(1):95-99. [discussion: 99].
37. Javid P.J., Malone F.R., Dick A.A., et al. A contemporary analysis of parenteral nutrition-associated liver disease in surgical infants. J Pediatr Surg 2011, 46(10):1913-1917.
38. Baird R., Eeson G., Safavi A., et al. Institutional practice and outcome variation in the management of congenital diaphragmatic hernia and gastroschisis in Canada: a report from the Canadian Pediatric Surgery Network. J Pediatr Surg 2011, 46(5):801-807.
39. Nehra D., Fallon E.M., Potemkin A.K., et al. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. JPEN J Parenter Enteral Nutr 2013, 1-9. 10.1177/0148607113492549.
40. Rollins M.D., Ward R.M., Jackson W.D., et al. Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: a pilot study. J Pediatr Surg 2013, 48(6):1348-1356.
41. Robinson D.T., Ehrenkranz R.A. Parenteral nutrition-associated cholestasis in small for gestational age infants. J Pediatr 2008, 152(1):59-62.
42. Grant D., Abu-Elmagd K., Reyes J., et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 2005, 241(4):607-613.
43. El Kasmi K.C., Anderson A.L., Devereaux M.W., et al. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease. Sci Transl Med 2013, 5(206):206ra137.
44. Premkumar M.H., Carter B.A., Hawthorne K.M., et al. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. J Pediatr 2013, 162(4):793-798.
45. Calkins K.L., Dunn J.C., Shew S.B., et al. Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil. JPEN J Parenter Enteral Nutr 2013, 1-11. 10.1177/0148607113495416.
46. Gura K.M., Lee S., Valim C., et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008, 121(3):e678-e686.
47. Goulet O., Antebi H., Wolf C., et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 2010, 34(5):485-495.
48. Koletzko B., Goulet O. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease. Curr Opin Clin Nutr Metab Care 2010, 13(3):321.
49. Skouroliakou M., Konstantinou D., Koutri K., et al. A double-blind, randomized clinical trial of the effect of ω-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr 2010, 64(9):940-947.
50. Tomsits E., Pataki M., Tölgyesi A., et al. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr 2010, 51(4):514-521.
51. Sanchez S.E., Braun L.P., Mercer L.D., et al. The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants. J Pediatr Surg 2013, 48(3):573-578.
52. Nehra D., Fallon E.M., Carlson S.J., et al. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr 2013, 37(4):498-505.
53. Rangel S.J., Calkins C.M., Cowles R.A., et al. Parenteral nutrition-associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2012, 47(1):225-240.
54. South A., Marshall D., Bose C., et al. Growth and neurodevelopment at 16 to 24 months of age for infants born with gastroschisis. J Perinatol 2008, 28(10):702-706.
55. Sondheimer J.M., Asturias E., Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998, 27(2):131-137.
56. Cowan E., Nandivada P., Puder M. Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease. Curr Opin Pediatr 2013, 25(2):193-200.
57. Kalish B.T., Le H.D., Gura K.M., et al. A metabolomic analysis of two intravenous lipid emulsions in a murine model. PLoS One 2013, 8(4):e59653.
58. Kalish B.T., Le H.D., Fitzgerald J.M., et al. Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators. Am J Physiol Gastrointest Liver Physiol 2013, 305(11):G818-G828.
59. Kurvinen A., Nissinen M.J., Gylling H., et al. Effects of long-term parenteral nutrition on serum lipids, plant sterols, cholesterol metabolism, and liver histology in pediatric intestinal failure. J Pediatr Gastroenterol Nutr 2011, 53(4):440-446.
60. Bindl L., Lütjohann D., Buderus S., et al. High plasma levels of phytosterols in patients on parenteral nutrition: a marker of liver dysfunction. J Pediatr Gastroenterol Nutr 2000, 31(3):313-316.
61. Forchielli M.L., Bersani G., Tala S., et al. The spectrum of plant and animal sterols in different oil-derived intravenous emulsions. Lipids 2010, 45(1):63-71.
62. Btaiche I.F., Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmacotherapy 2002, 22(2):188-211.
63. Boberg K.M., Stabursvik A., Bjorkhem I., et al. Dehydroxylation of a 7 beta-hydroxy-C27 plant sterol in rat liver. Biochim Biophys Acta 1989, 1004(3):321-326.
64. Liu Y., Binz J., Numerick M.J., et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 2003, 112(11):1678-1687.
65. Carter B.A., Taylor O.A., Prendergast D.R., et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007, 62(3):301-306.
66. Tomer G., Ananthanarayanan M., Weymann A., et al. Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Pediatr Res 2003, 53(2):288-294.
67. Moseley R.H., Wang W., Takeda H., et al. Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. Am J Physiol 1996, 271(1 Pt 1):G137-G146.
68. Ghose R., Zimmerman T.L., Thevananther S., et al. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2004, 2(1):4.
69. Deshpande G., Simmer K., Deshmukh M., et al. Randomized trial of fish oil (SMOFlipid) and olive oil lipid (clinoleic) in very preterm neonates. J Pediatr Gastroenterol Nutr 2013, 10.1097/mpg.0000000000000174.
70. Perez-Echarri N., Perez-Matute P., Marcos-Gomez B., et al. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats. J Nutr Biochem 2009, 20(9):705-714.
71. Takeuchi H., Kojima K., Sekine S., et al. Effect of dietary n-6/n-3 ratio on liver n-6/n-3 ratio and peroxisomal beta-oxidation activity in rats. J Oleo Sci 2008, 57(12):649-657.
72. Perez-Matute P., Perez-Echarri N., Martinez J.A., et al. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr 2007, 97(2):389-398.
73. Mak P.A., Laffitte B.A., Desrumaux C., et al. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J Biol Chem 2002, 277(35):31900-31908.
74. Claudel T., Inoue Y., Barbier O., et al. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology 2003, 125(2):544-555.
75. Butler T.J., Szekely L.J., Grow J.L. A standardized nutrition approach for very low birth weight neonates improves outcomes, reduces cost and is not associated with increased rates of necrotizing enterocolitis, sepsis or mortality. J Perinatol 2013, 33(11):851-857.
76. Mahieu L.M., De Muynck A.O., Ieven M.M., et al. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. J Hosp Infect 2001, 48(2):108-116.
77. Polin R.A., Saiman L. Nosocomial infections in the neonatal intensive care unit. Neoreviews 2003, 4(3):e81-e89.